KS900: A hypoxia-directed, reductively activated methylating antitumor prodrug that selectively ablates O(6)-alkylguanine-DNA alkyltransferase in neoplastic cells.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples